Title : Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer.

Pub. Date : 2013 Feb

PMID : 23386065






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The most frequent toxicities with crizotinib include mild visual disturbances, nausea, vomiting, diarrhea, constipation, edema, and generally reversible, sometimes severe, elevations in aspartate aminotransferase and alanine aminotransferase. Crizotinib glutamic--pyruvic transaminase Homo sapiens